The transition to digital in healthcare is happening at a fast pace.
Overall activity in deals jumped 11% in North America.
For founders and owners of privately held medical product businesses, the amount of private investment dollars available is significant.
A U.S. launch of the product is expected in just a few weeks.
It is the pot of gold at the end of the medical rainbow—the promise that, by harnessing data, researchers can tailor drugs, devices, and treatments to the genetic configuration, lifestyle, and environment of individual patients.
Medtech decision makers must accurately predict future trends in order to chart the best future directions and identify the most advantageous areas for business investment.
Three startup companies have made strong strides in helping patients with autism spectrum disorder.
There are several critical questions that your internal team should be ready to address when preparing product portfolios and seeking out a CRO.
The agency wants healthcare facilities to start using duodenoscopes that do not require reprocessing but recognizes the transition will take time.
Here’s a hint: EU MDR and recalls were among the hot topics.